Concatemerized Interneuron Enhancers for Stronger AAV Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing recombinant adeno-associated virus (rAAV) systems for gene delivery in GABAergic interneurons face limitations due to restricted packaging and weak gene expression, which hampers their effectiveness in research and therapeutic applications.
Innovation Solution
The development of concatemerized I56i enhancer elements, derived from human, murine, or zebrafish sequences, provides enhanced and rapid transgene expression in forebrain GABAergic interneurons, allowing for stronger and more efficient gene delivery vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If a single full-length I56i enhancer is used, then packaging size is reduced, but transgene expression strength and speed are insufficient
Solution Approach 1:
The patent segments the enhancer function by using multiple copies of a core enhancer sequence (3x concatemer) instead of one long sequence. Each copy contributes to the overall enhancer activity, achieving stronger and faster transgene expression while staying within AAV packaging limits.
Solution Approach 2:
The patent changes the enhancer configuration from a single full-length sequence to a concatemerized structure with multiple repeated units. This parameter change in enhancer architecture increases transcriptional activity and expression kinetics without exceeding vector capacity.
2Productivity
If lengthy genetic control elements are included to enhance expression, then transgene expression improves, but AAV packaging capacity is exceeded
Solution Approach 1:
The genetic control elements are segmented into multiple identical or similar units arranged in a concatemer. This allows the total functional equivalent of lengthy control elements to be achieved through repetition rather than single long sequences, fitting within AAV packaging constraints.
Solution Approach 2:
The core enhancer sequence serves multiple functions simultaneously: it acts as a transcriptional enhancer, provides structural organization for the concatemer, and can be repeated to scale functionality. This multi-functionality allows enhanced expression without proportionally increasing total sequence length.
Data Source
AI summary
Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. The artificial expression constructs can be used to selectively express synthetic genes or modify gene expression in GABAergic interneurons.